Molecular Imaging 2017

FDG-PET based RT planning in NSCLC: first clinical data

44 pat. NSCLC I-III, 10/44 mediastinal downstaging by PET

Dose escalation to 64,8 Gy/1,8 Gy b.i.d. GTV = tumor + FDG-PET positive LN-stations

18 local recurrences (41 %) after median follow up of 16 months 1 isolated out field recurrence at LN pre treatment N0 in CT and PET

De Ruysscher IJROBP 2005 62; 988-994

Slide 24